
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

UbriGene Biosciences, Circurna Partner to Accelerate Circular RNA/LNP Therapeutics
Details : The collaboration aims to advance the development of an undisclosed oligonucleotide product in cancer.
Product Name : Undisclosed
Product Type : Oligonucleotide
Upfront Cash : Undisclosed
December 09, 2025
